Sunrise Labs architects and implements innovative engineering solutions for ‘smart’ products that work. We are a product development company specializing in one-stop delivery of robust, reliable medical devices and industrial instrumentation.Eric, Laurin and Drew In 1992, Drew Sunstein founded our company to partner with clients and produce quality, practical, cost-effective design solutions with a sharp focus on time-to-market. We build products that work. Our products work for the end user, the manufacturer, and all service providers. With experience spanning the development progression, and a reputation for delivering on commitments, our team is the smart choice to tackle your product development challenges. Our engineers design quality in by fully understanding the requirements before designing or coding begins. Our ISO 9001 and ISO 13485 certified processes are built to stand alone or work in adjunct to your quality systems. Our facilities, services, and systems are flexible, allowing us to scale our efforts to support your needs and maximize efficiency. We honor our commitments and stand behind our engineering. From idea to implementation, we build innovative engineering solutions that result in “smart” products that work.
Adagio Medical, Inc. is a privately held company located in Laguna Hills, California developing innovative cryoablation technologies that create continuous, linear, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter and ventricular tachycardia.
TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.
Contraline, Inc. is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception. The company is developing ADAM™, the world`s first injectable hydrogel designed to provide long-lasting barrier contraception for men. The company was founded in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, Virginia.
Queens Hospital Center is a Jamaica, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.